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Clostridioides difficile infection (CDI) remains an urgent global One Health threat. The genetic 26 
heterogeneity seen across C. difficile underscores its wide ecological versatility and has driven the 27 
significant changes in CDI epidemiology seen in the last 20 years. We analysed an international 28 
collection of over 12,000 C. difficile genomes spanning the eight currently defined phylogenetic 29 
clades. Through whole-genome average nucleotide identity, and pangenomic and Bayesian 30 
analyses, we identified major taxonomic incoherence with clear species boundaries for each of the 31 
recently described cryptic clades CI-III. The emergence of these three novel genomospecies 32 
predates clades C1-5 by millions of years, rewriting the global population structure of C. difficile 33 
specifically and taxonomy of the Peptostreptococcaceae in general. These genomospecies all show 34 
unique and highly divergent toxin gene architecture, advancing our understanding of the evolution 35 
of C. difficile and close relatives. Beyond the taxonomic ramifications, this work may impact the 36 
diagnosis of CDI. 37 
 
Introduction 38 
The bacterial species concept remains controversial, yet it serves as a critical framework for all 39 
aspects of modern microbiology1. The prevailing species definition describes a genomically 40 
coherent group of strains sharing high similarity in many independent phenotypic and ecological 41 
properties2. The era of whole-genome sequencing (WGS) has seen average nucleotide identity 42 
(ANI) replace DNA-DNA hybridization as the next-generation standard for microbial taxonomy3, 4. 43 
Endorsed by the National Center for Biotechnology Information (NCBI)4, ANI provides a precise, 44 
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objective and scalable method for delineation of species, defined as monophyletic groups of strains 45 
with genomes that exhibit at least 96% ANI5, 6. 46 
 Clostridioides (Clostridium) difficile is an important gastrointestinal pathogen that places a 47 
significant growing burden on health care systems in many regions of the world7. In both its 20138 48 
and 20199 reports on antimicrobial resistance (AMR), the US Centers for Disease Control and 49 
Prevention rated C. difficile infection (CDI) as an urgent health threat, the highest level. 50 
Community-associated CDI has become more frequent7 and is linked to sources of C. difficile in 51 
animals and the environment10. Thus, over the last two decades, CDI has emerged as an important 52 
One Health issue10. 53 
Based on multi-locus sequence type (MLST), there are eight recognised monophyletic 54 
groups or ‘clades’ of C. difficile11. Strains within these clades show many unique clinical, 55 
microbiological, and ecological features11. Critical to the pathogenesis of CDI is the expression of 56 
the large clostridial toxins, TcdA and TcdB and, in some strains, binary toxin (CDT), encoded by 57 
two separate chromosomal loci, the PaLoc and CdtLoc, respectively12. Clade 1 (C1) contains over 58 
200 toxigenic and non-toxigenic sequence types (STs) including many of the most prevalent strains 59 
causing CDI worldwide e.g., ST2, ST8, and ST1711. Several highly virulent CDT-producing strains, 60 
including ST1 (PCR ribotype (RT) 027), a lineage associated with major hospital outbreaks in 61 
North America, Europe, and Latin America13, are found in clade 2 (C2). Comparatively little is 62 
known about clade 3 (C3) although it contains ST5 (RT 023), a toxigenic CDT-producing strain 63 
with characteristics that may make laboratory detection difficult14. C. difficile ST37 (RT 017) is 64 
found in clade 4 (C4) and, despite the absence of a toxin A gene, is responsible for much of the 65 
endemic CDI burden in Asia15. Clade 5 (C5) contains several CDT-producing strains including 66 
ST11 (RTs 078, 126 and others), which are highly prevalent in production animals worldwide16. 67 
The remaining so-called ‘cryptic’ clades (C-I, C-II and C-III), first described in 201217, 18, contain 68 
over 50 STs from clinical and environmental sources17, 18, 19, 20, 21. The evolution of the cryptic 69 
clades is poorly understood. Clade C-I strains can cause CDI, however, due to atypical toxin gene 70 
architecture, they may not be detected, thus their prevalence may have been underestimated21. 71 
There are over 600 STs currently described and some STs may have access to a gene pool of 72 
more than 10,000 genes11, 16, 22. Considering such enormous diversity, and recent contentious 73 
taxonomic revisions23, 24, we hypothesise that C. difficile comprises a complex of distinct species 74 
divided along the major evolutionary clades. In this study, whole-genome ANI, and pangenomic 75 
and Bayesian analyses are used to explore an international collection of over 12,000 C. difficile 76 
genomes, to provide new insights into ancestry, genetic diversity, and evolution of pathogenicity in 77 
this enigmatic pathogen. 78 
Results 79 
An updated global population structure based on sequence typing of 12,000 genomes. We 80 
obtained and determined the ST and clade for a collection of 12,621 C. difficile genomes (taxid ID 81 
1496, Illumina data) existing in the NCBI Sequence Read Archive (SRA) as of 1st January 2020. A 82 
total of 272 STs were identified spanning the eight currently described clades, indicating that the 83 
SRA contains genomes for almost 40% of known C. difficile STs worldwide (n=659, PubMLST, 84 
January 2020). C1 STs dominated the database in both prevalence and diversity (Fig. 1) with 149 85 
C1 STs comprising 57.2% of genomes, followed by C2 (35 STs, 22.9%), C5 (18 STs, 10.2%), C4 86 
(34 STs, 7.5%), C3 (7 STs, 2.0%) and the cryptic clades C-I, C-II and C-III (collectively 17 STs, 87 
0.2%). The five most prevalent STs represented were ST1 (20.9% of genomes), ST11 (9.8%), ST2 88 
(9.5%), ST37 (6.5%) and ST8 (5.2%), all prominent lineages associated with CDI worldwide11.  89 
 Fig. 2 shows an updated global C. difficile population structure based on the 659 STs; 27 90 
novel STs were found (an increase of 4%) and some corrections to assignments within C1 and C2 91 
were made, including assigning ST12225 to C1. Based on PubMLST data and bootstraps values of 92 
1.0 in all monophyletic nodes of the cryptic clades (Fig. 2), we could confidently assign 25, 9 and 93 
10 STs to cryptic clades I, II and III, respectively. There remained 26 STs spread across the 94 
phylogeny that did not fit within a specific clade (defined as outliers). The tree file for Fig. 2 and 95 
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full MLST data is available as Supplementary Files 1a-1d and 2 at 96 
http://doi.org/10.6084/m9.figshare.12471461. Representative genomes of each ST present in the 97 
ENA were chosen based on metadata, read depth and assembly quality. This resulted in a final 98 
dataset of 260 STs (C1, n=149; C2, n=35; C3, n=7; C4, n=34; C5, n=18; C-I, n=12; C-II, n=3, C-99 
III, n=2) used for all subsequent bioinformatics analyses. The list of representative genomes is 100 




Figure 1. Composition of C. difficile genomes in the NCBI SRA. Snapshot obtained 1st January 2020; 102 
12,304 strains, [taxid ID 1496]. (A) Top 40 most prevalent STs in the NCBI SRA coloured by clade. (B) The 103 
proportion of genomes in ENA by clade. (C) Number/ proportion of STs per clade found in the SRA/present 104 
in the PubMLST database. (D) Annual and cumulative deposition of C. difficile genome data in ENA. 105 
 
 
Whole-genome ANI analysis reveals clear species boundaries. Whole-genome ANI analyses 106 
were used to investigate genetic discontinuity across the C. difficile species (Fig. 3 and 107 
Supplementary File 1f). Whole-genome ANI values were determined for the final set of 260 STs 108 
using three independent ANI algorithms (FastANI, ANIm and ANIb, see Methods). All 225 109 
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genomes belonging to clades C1-4 clustered within an ANI range of 97.1-99.8% (median FastANI 110 
values of 99.2, 98.7, 97.9 and 97.8%, respectively, Fig. 3A-C). 111 
 
 
Figure 2. C. difficile population structure. (A) NJ phylogeny of 659 aligned, concatenated, multilocus 112 
sequence type allele combinations coloured by current PubMLST clade assignment. Black bars indicate 113 
WGS available for ANI analysis (n=260). (B) A subset of the NJ tree showing cryptic clades C-I, C-II and C-114 
III. Again, black bars indicate WGS available for ANI analysis (n=17). 115 
 
 
These ANI values are above the 96% species demarcation threshold used by the NCBI4 and indicate 116 
that strains from these clades belong to the same species. ANI values for all 18 genomes belonging 117 
to C5 clustered on the borderline of the species demarcation threshold (FastANI range 95.9-96.2%, 118 
median 96.1%). ANI values for all three cryptic clades fell well below the species threshold; C-I 119 
(FastANI range 90.9-91.1%, median 91.0%), C-II (FastANI range 93.6-93.9%, median 93.7%) and 120 
C-III (FastANI range 89.1-89.1%, median 89.1%). All results were corroborated across the three 121 
independent ANI algorithms (Fig. 3A-C). C. difficile strain ATCC 9689 (ST3, C1) was defined by 122 
Lawson et al. as the type strain for the species23, and used as a reference in all the above analyses. 123 
To better understand the diversity among the divergent clades themselves, FastANI analyses were 124 
repeated using STs 11, 181, 200 and 369 as reference archetypes of clades C5, C-I, C-II and C-III, 125 
respectively. This approach confirmed that C5 and the three cryptic clades were as distinct from 126 






Figure 3. Species-wide ANI analysis. Panels A-C show ANI plots for ST3 (C1) vs. all clades (260 STs) 128 
using FastANI, ANIm and ANIb algorithms, respectively. Panels D-G show ANI plots for ST11 (C5), 129 
ST181 (C-I), ST200 (C-II) and ST369 (C-III) vs all clades (260 STs), respectively. NCBI species 130 





Taxonomic placement of cryptic clades predates C. difficile emergence by millions of years. 132 
Previous studies using BEAST have estimated the common ancestor of C1-5 existed between 1 to 133 
85 or 12 to 14 million years ago (mya)26, 27. Here, we used an alternative Bayesian approach, 134 
BactDating, to estimate the age of all eight C. difficile clades currently described. The last common 135 
ancestor for C. difficile clades C1-5 was estimated to have existed between 1.11 to 6.71 mya. In 136 
contrast, all three cryptic clades were estimated to have emerged millions of years prior to the 137 
common ancestor of C1-5 (Fig. 4). Independent analysis with BEAST, using a smaller core gene 138 
dataset (see Methods), provided temporal estimates of clade emergence that were of the same order 139 
of magnitude and, importantly, supported the same branching order for all clades (Fig. 4).  140 
 
 
Figure 4. Bayesian analysis of species and clade divergence. BactDating and BEAST estimates of the age 141 
of major C. difficile clades. Node dating ranges for both Bayesian approaches are transposed onto an ML 142 
phylogeny built from concatenated MLST alleles of a dozen STs from each clade. Archetypal STs in each 143 
evolutionary clade are indicated. The tree is midpoint rooted and bootstrap values are shown (all 144 
bootstrapping values of the cryptic clade branches are 100%). Scale bar indicates the number of substitutions 145 
per site. BactDating estimates the median time of the most recent common ancestor of C1-5 at 3.89 million 146 
years ago (mya) [95% credible interval (CI), 1.11-6.71 mya]. Of the cryptic clades, C-II shared the most 147 
recent common ancestor with C1-5 (13.05 mya, 95% CI 3.72-22.44 mya), followed by C-I (22.02 mya, 95% 148 
CI 6.28-37.83 mya), and C-III (47.61 mya, 95% CI 13.58-81.73 mya). Comparative temporal estimates from 149 
BEAST show the same order of magnitude and support the same branching order [clades C1-5 (12.01 mya, 150 
95% CI 6.80-33.47 mya); C-II (37.12 mya, 95% CI 20.95-103.48 mya); C-I (65.93 mya, 95% CI 37.32-151 
183.84 mya); C-III (142.13 mya, 95% CI 79.77-397.18 mya)]. 152 
Next, to identify their true taxonomic placement, ANI was determined for ST181 (C-I), ST200 (C-153 
II) and ST369 (C-III) against two reference datasets. The first dataset comprised 25 species 154 
belonging to the Peptostreptococcaceae as defined by Lawson et al.23 in their 2016 reclassification 155 
of Clostridium difficile to Clostridioides difficile. The second dataset comprised 5,895 complete 156 
genomes across 21 phyla from the NCBI RefSeq database (accessed 14th January 2020), including 157 
1,366 genomes belonging to Firmicutes, 92 genomes belonging to 15 genera within the 158 
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Clostridiales and 20 Clostridium and Clostridioides species. The nearest ANI matches to species 159 
within the Peptostreptococcaceae dataset were C. difficile (range 89.3-93.5% ANI), 160 
Asaccharospora irregularis (78.9-79.0% ANI) and Romboutsia lituseburensis (78.4-78.7% ANI). 161 
Notably, Clostridioides mangenotii, the only other known member of Clostridioides, shared only 162 
77.2-77.8% ANI with the cryptic clade genomes (Table 1).   163 
 
Table 1 Whole-genome ANI analysis of cryptic clades vs. 25 Peptostreptococcaceae species 164 
from Lawson et al23. 165 
Species NCBI accession 
ANI % 
ST181 (C-I) ST200 (C-II) ST369 (C-III) 
Clostridioides difficile (ST3) AQWV00000000.1 91.11 93.54 89.30 
Asaccharospora irregularis NZ_FQWX00000000 78.94 78.87 78.91 
Romboutsia lituseburensis NZ_FNGW00000000.1 78.51 78.36 78.66 
Romboutsia ilealis LN555523.1 78.45 78.54 78.44 
Paraclostridium benzoelyticum NZ_LBBT00000000.1 77.92 77.71 78.14 
Paraclostridium bifermentans NZ_AVNC00000000.1 77.89 77.89 78.06 
Clostridioides mangenotii GCA_000687955.1 77.82 77.84 78.15 
Paeniclostridium sordellii NZ_APWR00000000.1 77.73 77.59 77.86 
Clostridium hiranonis NZ_ABWP01000000 77.52 77.42 77.59 
Terrisporobacter glycolicus NZ_AUUB00000000.1 77.47 77.53 77.53 
Intestinibacter bartlettii NZ_ABEZ00000000.2 77.29 77.52 77.48 
Clostridium paradoxum NZ_LSFY00000000.1 76.60 76.65 76.93 
Clostridium thermoalcaliphilum NZ_MZGW00000000.1 76.49 76.61 76.85 
Tepidibacter formicigenes NZ_FRAE00000000.1 76.41 76.47 76.38 
Tepidibacter mesophilus NZ_BDQY00000000.1 76.38 76.44 76.22 
Tepidibacter thalassicus NZ_FQXH00000000.1 76.34 76.31 76.46 
Peptostreptococcus russellii NZ_JYGE00000000.1 76.30 76.08 76.38 
Clostridium formicaceticum NZ_CP020559.1 75.18 75.26 75.62 
Clostridium caminithermale FRAG00000000 74.97 75.07 75.03 
Clostridium aceticum NZ_JYHU00000000.1 ≤70.00 ≤70.00 ≤70.00 
Clostridium litorale FSRH01000000 ≤70.00 ≤70.00 ≤70.00 
Eubacterium acidaminophilum NZ_CP007452.1 ≤70.00 ≤70.00 ≤70.00 
Filifactor alocis NC_016630.1 ≤70.00 ≤70.00 ≤70.00 
Peptostreptococcus anaerobius ARMA01000000 ≤70.00 ≤70.00 ≤70.00 
Peptostreptococcus stomatis NZ_ADGQ00000000.1 ≤70.00 ≤70.00 ≤70.00 
 
Similarly, the nearest ANI matches to species within the RefSeq dataset were several C. difficile 166 
strains (range C-I: 90.9-91.1%; C-II: 93.4-93.6%; and C-III: 89.2-89.4%) and Paeniclostridium 167 
sordellii (77.7-77.9%). A low ANI (range ≤70-75%) was observed between the cryptic clade 168 
genomes and 20 members of the Clostridium including C. tetani, C. botulinum, C. perfringens and 169 
C. butyricum, the type strain of the Clostridium genus senso stricto. An updated ANI-based 170 
taxonomy for the Peptostreptococcaceae is shown in Fig. 5A. The phylogeny places C-I, C-II and 171 
C-III between C. mangenotii and C. difficile C1-5, suggesting that they should be assigned to the 172 
Clostridioides genus, distinct from both C. mangenotii and C. difficile. Comparative analysis of 173 
ANI and 16S rRNA values for the eight C. difficile clades and C. mangenotii shows significant 174 
incongruence between the data generated by the two approaches (Fig. 5B). The range of 16S rRNA 175 
% similarity between C. difficile C1-4, cryptic clades I-III and C. mangenotii was narrower (range 176 
94.5-100) compared to the range of ANI values (range 77.8-98.7). Curiously, C. mangenotii and C. 177 
difficile shared 94.5-94.7% similarity in 16s rRNA sequence identity, yet only 77.8-78.2% ANI, 178 
indicating they should not even be considered within the same genus, as proposed by Lawson et 179 
al.23 180 
We also extended our approach to five other medically important clostridia available on the 181 
NCBI database; Clostridium botulinum (n=783), Clostridium perfringens (n=358), Clostridium 182 
sporogenes (n=100), Clostridium tetani (n=32), and Paeniclostridium sordellii (formerly 183 
Clostridium sordellii, n=46). We found that three out of the five species (C. perfringens, C. 184 
sporogenes, and C. botulinum) showed evidence of taxonomic discontinuity similar to that observed 185 
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for C. difficile (e.g., a proportion of strains with pairwise ANI below the 96% demarcation 186 
threshold). This was most notable for C. sporogenes and C. botulinum, where there were many 187 
sequenced strains with a pairwise ANI below 90% (8% and 31% of genomes, respectively, 188 




Figure 5. Revised taxonomy for the Peptostreptococcaceae. (A) ANI-based minimum evolution tree 190 
showing evolutionary relationship between eight C. difficile ‘clades’ along with 17 members of the 191 
Peptostreptococcaceae (from Lawson et al23) as well as Clostridium butyricum as the outgroup and type 192 
strain of the Clostridium genus senso stricto. To convert the ANI into a distance, its complement to 1 was 193 
taken. (B) Matrices showing pairwise ANI and 16S rRNA values for the eight C. difficile clades and C. 194 
mangenotii, the only other known member of Clostridioides. 195 
 
Evolutionary and ecological insights from the C. difficile species pangenome. Next, we sought 196 
to quantify the C. difficile species pangenome and identify genetic loci that are significantly 197 
associated with the taxonomically divergent clades. With Panaroo, the C. difficile species 198 
pangenome comprised 17,470 genes, encompassing an accessory genome of 15,238 genes and a 199 
core genome of 2,232 genes, just 12.8% of the total gene repertoire (Fig 6). The size of the 200 
pangenome reduced by 2,082 genes with the exclusion of clades CI-III, and a further 519 genes 201 
with the exclusion of C5. Compared to Panaroo, Roary overestimated the size of the pangenome 202 
(32,802 genes, 87.7% overestimation), resulting in markedly different estimates of the percentage 203 
core genome, 3.9 and 12.8%, respectively (χ2=1,395.3, df=1, p<0.00001). The overestimation of 204 
pangenome was less pronounced when the identity threshold was decreased to 90% (42.0% 205 
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overestimation) and when the paralogs were merged (28.7% overestimation). Panaroo can account 206 
for errors introduced during assembly and annotation, thus polishing the 260 Prokka-annotated 207 
genomes with Panaroo resulted in a significant reduction in gene content per genome (median 208 
2.48%; 92 genes, range 1.24-12.40%; 82-107 genes, p<0.00001). The C. difficile species 209 
pangenome was determined to be open28 (Fig 6).  210 
Pan-GWAS analysis with Scoary revealed 142 genes with significant clade specificity. 211 
Based on KEGG orthology, these genes were classified into four functional categories: 212 
environmental information processing (7), genetic information processing (39), metabolism (43), 213 
and signaling and cellular processes (53). We identified several uniquely present, absent, or 214 
organised gene clusters associated with ethanolamine catabolism (C-III), heavy metal uptake (C-215 
III), polyamine biosynthesis (C-III), fructosamine utilization (C-I, C-III), zinc transport (C-II, C5) 216 
and folate metabolism (C-I, C5). A summary of the composition and function of these major 217 
lineage-specific gene clusters is given in Table 2, and a comparative analysis of their respective 218 
genetic architecture can be found in Supplementary File 1h.  219 
 
Figure 6. Clostridioides difficile species pangenome. (A) Pan and core genome estimates for all 260 STs, 220 
clades C1-4 (n=242 STs) and clades C1-5 (n=225 STs). (B) The difference in % core genome and 221 
pangenome sizes with Panaroo and Roary algorithms. (*) indicates χ2 p < 0.00001 and (**) indicates χ2 p = 222 
0.0008. (C) The proportion of retained genes per genome after polishing Prokka-annotated genomes with 223 
Panaroo. (D) The total number of genes in the pan (grey) and core (black) genomes are plotted as a function 224 
of the number of genomes sequentially added (n=260). Following the definition of Tettelin et al.28, the C. 225 
difficile species pangenome showed characteristics of an “open” pangenome. First, the pangenome increased 226 
in size exponentially with sampling of new genomes. At n=260, the pangenome exceeded more than double 227 
the average number of genes found in a single C. difficile genome (~3,700) and the curve was yet to reach a 228 
plateau or exponentially decay, indicating more sequenced strains are needed to capture the complete species 229 
gene repertoire. Second, the number of new ‘strain-specific’ genes did not converge to zero upon sequencing 230 
of additional strains, at n=260, an average of 27 new genes were contributed to the gene pool. Finally, 231 
according to Heap’s Law, α values of ≤ 1 are representative of open pangenome. Rarefaction analysis of our 232 
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pangenome curve using a power-law regression model based on Heap’s Law28 showed the pangenome was 233 
predicted to be open (Bpan (≈ α28) = 0.47, curve fit, r2=0.999). (E) Presence absence variation (PAV) matrix 234 
for 260 C. difficile genomes is shown alongside a maximum-likelihood phylogeny built from a 235 
recombination-adjusted alignment of core genes from Panaroo (2,232 genes, 2,606,142 sites).  236 
 
Table 2 Major clade-specific gene clusters identified by pan-GWAS  237 
Protein Gene Clade specificity Functional insights 
Ethanolamine kinase ETNK, EKI Unique to C-III and is in 
addition to the highly 
conserved eut cluster 
found in all lineages.  Has 
a unique composition and 
includes six additional 
genes that are not present 
in the traditional CD630 
eut operon or any other 
non-C-III strains. 
An alternative process for the 
breakdown of ethanolamine and 
its utilization as a source of 







1-propanol dehydrogenase pduQ 
Ethanolamine utilization protein EutS eutS 
Ethanolamine utilization protein EutP eutP 
Ethanolamine ammonia-lyase large subunit eutB 
Ethanolamine ammonia-lyase small subunit eutC 
Ethanolamine utilization protein EutL eutL 
Ethanolamine utilization protein EutM eutM 
Acetaldehyde dehydrogenase E1.2.1.10 
Putative phosphotransacetylase K15024 
Ethanolamine utilization protein EutN eutN 
Ethanolamine utilization protein EutQ eutQ 
TfoX/Sxy family protein - 
Iron complex transport system permease protein ABC.FEV.P Unique to C-III Multicomponent transport 
system with specificity for 
chelating heavy metal ions. 
  
Iron complex transport system ATP-binding protein ABC.FEV.A 
Iron complex transport system substrate-binding protein ABC.FEV.S 
Hydrogenase nickel incorporation protein HypB hypB 
Putative ABC transport system ATP-binding protein yxdL 
Class I SAM-dependent methyltransferase - 
Peptide/nickel transport system substrate-binding protein ABC.PE.S 
Peptide/nickel transport system permease protein ABC.PE.P 
Peptide/nickel transport system permease protein ABC.PE.P1 
Peptide/nickel transport system ATP-binding protein ddpD 
Oligopeptide transport system ATP-binding protein oppF 
Class I SAM-dependent methyltransferase - 
Heterodisulfide reductase subunit D [EC:1.8.98.1] hdrD Unique to C-III and is in 
addition to  
the highly conserved 
spermidine uptake cluster 
found in all other lineages.   
Alternative spermidine uptake 
processes which may play a role 
in stress response to nutrient 
limitation. The additional cluster 
has homologs in Romboutsia, 
Paraclostridium and 
Paeniclostridium spp.  
CDP-L-myo-inositol myo-inositolphosphotransferase dipps 
Spermidine/putrescine transport system substrate-binding protein ABC.SP.S 
Spermidine/putrescine transport system permease protein ABC.SP.P1 
Spermidine/putrescine transport system permease protein ABC.SP.P 
Spermidine/putrescine transport system ATP-binding protein potA 
Sigma -54 dependent transcriptional regulator gfrR Present in all lineages 
except C-I. Cluster found 
in a different genomic 
position in C-III. 
Mannose-type PTS system 
essential for utilization of 
fructosamines such as 
fructoselysine and 
glucoselysine, abundant 
components of rotting fruit and 
vegetable matter.  
Fructoselysine/glucoselysine PTS system EIIB component gfrB 
Mannose PTS system EIIA component manXa 
Fructoselysine/glucoselysine PTS system EIIC component gfrC 
Fructoselysine/glucoselysine PTS system EIID component gfrD 
SIS domain-containing protein - 
Fur family transcriptional regulator, ferric uptake regulator furB Unique to C-II and C5 
  
Associated with EDTA 
resistance in E.coli, helping the 
bacteria survive in Zn-depleted 
environment.  
Zinc transport system substrate-binding protein znuA 
Fe-S-binding protein yeiR 
Rrf2 family transcriptional regulator - 
Putative signalling protein - Unique to C-I and C5 STs 
163, 280, and 386   
In E. coli, AbgAB proteins 
enable uptake and cleavage of 
the folate catabolite p-
aminobenzoyl-glutamate, 
allowing the bacterium to 
survive on exogenous sources 
of folic acid. 
Aminobenzoyl-glutamate utilization protein B abgB 
MarR family transcriptional regulator - 
   
Cryptic clades CI-III possessed highly divergent toxin gene architecture. Overall, 68.8% 238 
(179/260) of STs harboured tcdA (toxin A) and/or tcdB (toxin B), the major virulence factors in 239 
C. difficile, while 67 STs (25.8%) harboured cdtA/cdtB (binary toxin). The most common genotype 240 
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was A+B+CDT- (113/187; 60.4%), followed by A+B+CDT+ (49/187; 26.2%), A-B+CDT+ (10/187; 241 
5.3%), A-B-CDT+ (8/187; 4.3%) and A-B+CDT- (7/187; 3.7%). Toxin gene content varied across 242 
clades (C1, 116/149, 77.9%; C2, 35/35, 100.0%; C3, 7/7, 100.0%; C4, 6/34, 17.6%; C5, 18/18, 243 
100.0%; C-I, 2/12, 16.7%; C-II, 1/3, 33.3%; C-III, 2/2, 100.0%) (Fig. 7). 244 
 
 
Figure 7. Toxin gene analysis. (A) Distribution of toxin genes across C. difficile clades (n=260 STs). 245 
Presence is indicated by black bars and absence by light blue bars. (B) Comparison of PaLoc architecture in 246 
the chromosome of strain R20291 (C2, ST1) and cognate chromosomal regions in genomes of cryptic STs 247 
649 (C-I), 637 (C-II), and 369 (C-III). All three cryptic STs show atypical ‘monotoxin’ PaLoc structures, 248 
with the presence of syntenic tcdR, tcdB, and tcdE, and the absence of tcdA, tcdC, cdd1 and cdd2. ST369 249 
genome ERR2215981 shows colocalization of the PaLoc and CdtLoc, see below. (C) Comparison of CdtLoc 250 
architecture in the chromosome of strain R20291 (C2, ST1) and cognate chromosomal regions in genomes of 251 
cryptic STs 649/644 (C-I) and 343/369 (C-III). Several atypical CdtLoc features are observed; cdtR is absent 252 
in ST649, and an additional copy of cdtA is present in ST369, the latter comprising part of a CdtLoc co-253 
located with the PaLoc. (D) Amino acid differences in TcdB among cryptic STs 649, 637, and 369 and 254 
reference strains from clades C1-5. Variations are shown as black lines relative to CD630 (C1, ST54). 255 
Phylogenies constructed from the catalytic and protease domains (in blue) and translocation and receptor-256 
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binding domains (in orange) of TcdB for the same eight STs included in (D). Scale bar shows the number of 257 
amino acid substitutions per site. Trees are mid-point rooted and supported by 500 bootstrap replicates. 258 
 
Critically, at least one ST in each of clades C-I, C-II and C-III harboured divergent tcdB (89-94% 259 
identity to tcdBR20291) and/or cdtAB alleles (60-71% identity to cdtAR20291, 74-81% identity to 260 
cdtBR20291). These genes were located on atypical and novel PaLoc and CdtLoc structures flanked 261 
by mediators of lateral gene transfer (Fig. 7). Sequence types 359, 360, 361 and 649 (C-I), 637 (C-262 
II) and 369 (C-III) harboured ‘monotoxin’ PaLocs characterised by the presence of syntenic tcdR, 263 
tcdB and tcdE, and complete absence of tcdA and tcdC. In STs 360 and 361 (C-I), and 637 (C-II), a 264 
gene encoding an endolysin with predicted N-acetylmuramoyl-L-alanine amidase activity (cwlH) 265 
was found adjacent to the phage-derived holin gene tcdE.  266 
Remarkably, a full CdtLoc was found upstream of the PaLoc in ST369 (C-III). This CdtLoc 267 
was unusual, characterised by the presence of cdtB, two copies of cdtA, two copies of cdtR and xerC 268 
encoding a site-specific tyrosine recombinase (Fig. 7). Both ST644 (C-I) and ST343 (C-III) were 269 
CdtLoc-positive but PaLoc-negative (A-B-CDT+). In ST649 (C-I) cdtR was completely absent and, 270 
in ST343 (C-III), the entire CdtLoc was contained within the genome of a 56Kbp temperate 271 
bacteriophage termed ΦSemix9P129. Toxin regulators TcdR and CdtR are highly conserved across 272 
clades C1-521. In contrast, the CdtR of STs 644 (C-I), 343 (C-III) and 369 (C-III) shared only 46-273 
54% amino acid identity (AAI) with CdtR of strain R20291 from clade 2 and ~40% AAI to each 274 
other. Similarly, the TcdR of ST 369 shared only 82.1% AAI compared to R20291 275 
(Supplementary File 1m). 276 
Compared to TcdB of R20291 (TcdBR20291), the shared AAI for TcdBST649_C-I, TcdBST637_C-II 277 
and TcdBST369_C-III were 94.0%, 90.5% and 89.4%, respectively. This sequence heterogeneity was 278 
confirmed through the detection of five distinct HincII/AccI digestion profiles of tcdB B1 fragments 279 
possibly reflecting novel toxinotypes (Supplementary File 1n). TcdB phylogenies identified clade 280 
C2 as the most recent common ancestor for TcdBST649_C-I (Fig. 7). Phylogenetic subtyping analysis 281 
of the TcdB receptor-binding domain (RBD) showed the respective sequences in C-I, C-II and C-III 282 
clustered with tcdB alleles belonging to virulent C2 strains (Supplementary File 1o). Notably, the 283 
TcdB-RBD of ST649 (C-I) shared an AAI of 93.5% with TcdB-RBD allele type 8 belonging to 284 
hypervirulent STs 1 (RT027)13 and 231 (RT251)30. Similarly, the closest match to tcdB-RBDs of 285 
ST637 (C-II) and ST369 (C-III) was allele type 10 (ST41, RT244)31.  286 
Discussion  287 
Through phylogenomic analysis of the largest and most diverse collection of C. difficile genomes to 288 
date, we identified major incoherence in C. difficile taxonomy, provide the first WGS-based 289 
phylogeny for the Peptostreptococcaceae and provide new insight into intra-species diversity and 290 
evolution of pathogenicity in this major One Health pathogen.  291 
Our analysis found high nucleotide identity (ANI > 97%) between C. difficile clades C1-4, 292 
indicating that strains from these four clades (comprising 560 known STs) belong to the same 293 
species. On the other hand, ANI between C5 and C1-4 is on the borderline of the accepted species 294 
threshold (95.9-96.2%). This degree of speciation likely reflects the unique ecology of C5 – a 295 
lineage comprising 33 known STs which is well established in non-human animal reservoirs 296 
worldwide and associated with CDI in the community setting32. Conversely, we identified major 297 
taxonomic incoherence among the three cryptic clades and C1-5, evident by ANI values (compared 298 
to ST3, C1) far below the species threshold (~91%, C-I; ~94%, C-II; and ~89%, C-III). Similar ANI 299 
value differences were seen between the cryptic clades themselves, indicating they are as divergent 300 
from each other as they are individually from C1-5. This extraordinary level of discontinuity is 301 
substantiated by our core genome and Bayesian analyses. Our study estimated the most recent 302 
common ancestor of C. difficile clades C1-4 and C1-5 existed between 0.46 to 2.77 mya and 303 
between 1.11 to 6.71 mya, respectively, whereas the common ancestors of clades C-I, C-II and C-III 304 
were estimated to have existed at least 1.5 to 75 million years before the common ancestor of C1-5. 305 
For context, divergence dates for other notable pathogens range from 10 Ma (Campylobacter coli 306 
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and C. jejuni)33, 47 Ma (Burkholderia pseudomallei and B. thailandensis)34 and 120 Ma 307 
(Escherichia coli and Salmonella enterica)35. Corresponding whole-genome ANI values for these 308 
species are 86%, 94% and 82%, respectively (Supplementary File 1j).  309 
Although BEAST provided wider confidence intervals (and therefore less certainty compared to 310 
BactDating), it estimates the time of divergence for all clades within the same order of magnitude 311 
and, importantly, provides robust support for the same branching order of clades with clade C-III 312 
the most ancestral of lineages, followed by the emergence of C-I, C-II, and C5. After this point, 313 
there appears to have been rapid population expansion into the four closely related clades described 314 
today, which include many of the most prevalent strains causing healthcare-associated CDI 315 
worldwide11. 316 
 We acknowledge that the dating of ancient taxa is often imprecise and that using a strict 317 
clock model for such a diverse set of taxa leads to considerable uncertainty in divergence estimates. 318 
However, we tried to mitigate this as much as possible by using two independent tools and 319 
evaluated multiple molecular clock estimates (covering almost an order of magnitude), ultimately 320 
using the same fixed clock model as Kumar et al.27 (2.5x10-9-1.5x10-8). The branching order of the 321 
clades is robust, supported by comprehensive and independent comparative genomic and 322 
phylogenomic analyses. Notwithstanding this finding, if variations in the molecular clock happen 323 
over time and across lineages, which is likely the case for such a genetically diverse spore-forming 324 
pathogen, then the true age ranges for C. difficile clade emergence are likely far greater (and 325 
therefore less certain) than we report here. 326 
Comparative ANI analysis of the cryptic clades with >5000 reference genomes across 21 327 
phyla failed to provide a better match than C. difficile (89-94% ANI). Similarly, our revised ANI-328 
based taxonomy of the Peptostreptococcaceae placed clades C-I, C-II and C-III between C. difficile 329 
and C. mangenotii. Our analyses of the Clostridioides spp. highlights the major discordance 330 
between WGS data and 16s rRNA data which has historically been used to classify bacterial 331 
species. In 2016, Lawson et al23 used 16s rRNA data to categorise C. difficile and C. mangenotii as 332 
the sole members of the Clostridioides. These species have 94.7% similarity in 16s rRNA sequence 333 
identity, yet our findings indicate that C. mangenotii and C. difficile share 77% ANI and should not 334 
be considered within the same genus. The rate of 16S rRNA divergence in bacteria is estimated to 335 
be 1–2% per 50 Ma35. Contradicting our ANI and core genome data, 16S rRNA sequences were 336 
highly conserved across all 8 clades. This indicates that in C. difficile, 16S rRNA gene similarity 337 
correlates poorly with measures of genomic, phenotypic and ecological diversity, as reported in 338 
other taxa such as Streptomyces, Bacillus and Enterobacteriaceae36, 37. Another interesting 339 
observation is that C5 and the three cryptic clades had a high proportion (>90%) of MLST alleles 340 
that were absent in other clades (Supplementary File 1e) suggesting minimal exchange of essential 341 
housekeeping genes between these clades. Whether this reflects divergence or convergence of two 342 
species, as seen in Campylobacter38, is unknown. Taken together, these data strongly support the 343 
reclassification of C. difficile clades C-I, C-II and C-III as novel independent Clostridioides 344 
genomospecies. There have been similar genome-based reclassifications in Bacillus39, 345 
Fusobacterium40 and Burkholderia41. Also, a recent Consensus Statement42 argues that the 346 
genomics and big data era necessitate easing of nomenclature rules to accommodate genome-based 347 
assignment of species status to nonculturable bacteria and those without ‘type material’, as is the 348 
case with these genomospecies.  349 
We also found that the significant taxonomic incoherence observed in C. difficile was also 350 
evident in other medically important clostridia, supporting calls for taxonomic revisions23, 24. The 351 
entire published collections of C. perfringens, C. sporogenes and C. botulinum all contained 352 
sequenced strains with pairwise ANI below the 96% demarcation threshold, with 8% of 353 
C. sporogenes and 31% of C. botulinum sequenced strains below 90% ANI. These findings 354 
highlight a significant problem with the current classification of the clostridia and further 355 
demonstrate that high-resolution approaches such as whole-genome ANI can be a powerful tool for 356 
the re-classification of these bacteria23, 24, 42. 357 
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The NCBI SRA was dominated by C1 and C2 strains, both in number and diversity. This 358 
apparent bias reflects the research community’s efforts to sequence the most prominent strains 359 
causing CDI in regions with the highest-burden, e.g. ST 1 from humans in Europe and North 360 
America. As such, there is a paucity of sequenced strains from diverse environmental sources, 361 
animal reservoirs or regions associated with atypical phenotypes. Cultivation bias - a historical 362 
tendency to culture, preserve and ultimately sequence C. difficile isolates that are concordant with 363 
expected phenotypic criteria, comes at the expense of ‘outliers’ or intermediate phenotypes. 364 
Members of the cryptic clades fit this criterion. They were first identified in 2012 but have been 365 
overlooked due to atypical toxin architecture which may compromise diagnostic assays (discussed 366 
below). Our updated MLST phylogeny shows as many as 55 STs across the three cryptic clades (C-367 
I, n=25; C-II, n=9; C-III, n=21) (Fig. 2). There remains a further dozen ‘outliers’ that could either 368 
fit within these new taxa or be the first typed representative of additional genomospecies. The 369 
growing popularity of metagenomic sequencing of animal and environmental microbiomes will 370 
certainly identify further diversity within these taxa, including nonculturable strains43, 44. 371 
By analysing 260 STs across eight clades, we provide the most comprehensive pangenome 372 
analysis of C. difficile to date. Importantly, we also show that the choice of algorithm significantly 373 
affects pangenome estimation. The C. difficile pangenome was determined to be open (i.e., an 374 
unlimited gene repertoire) and vast in scale (over 17000 genes), much larger than previous 375 
estimates (~10000 genes) which mainly considered individual clonal lineages16, 22. Conversely, 376 
comprising just 12.8% of its genetic repertoire (2,232 genes), the core genome of C. difficile is 377 
remarkably small, consistent with earlier WGS and microarray-based studies describing ultralow 378 
genome conservation in C. difficile11, 45. Considering only C1-5, the pangenome reduced in size by 379 
12% (2,082 genes); another 519 genes were lost when considering only C1-4. These findings are 380 
consistent with our taxonomic data, suggesting the cryptic clades, and to a lesser extent C5, 381 
contribute a significant proportion of evolutionarily divergent and unique loci to the gene pool. A 382 
large open pangenome and small core genome are synonymous with a sympatric lifestyle, 383 
characterised by cohabitation with, and extensive gene transfer between, diverse communities of 384 
prokarya and archaea46. Indeed, C. difficile shows a highly mosaic genome comprising many 385 
phages, plasmids and integrative and conjugative elements11, and has adapted to survival in multiple 386 
niches including the mammalian gastrointestinal tract, water, soil and compost, and invertebrates32.  387 
Through a robust Pan-GWAS approach we identified loci that are enriched or unique in the 388 
genomospecies. C-I strains were associated with the presence of transporter AbgB and absence of a 389 
mannose-type phosphotransferase (PTS) system. In E. coli, AbgAB proteins allow it to survive on 390 
exogenous sources of folate47. In many enteric species, the mannose-type PTS system is essential 391 
for catabolism of fructosamines such as glucoselysine and fructoselysine, abundant components of 392 
rotting fruit and vegetable matter48. C-II strains contained Zn transporter loci znuA and yeiR, in 393 
addition to Zn transporter ZupT which is highly conserved across all eight C. difficile clades. 394 
S. enterica and E. coli harbour both znuA/yeiR and ZupT loci, enabling survival in Zn-depleted 395 
environments49. C-III strains were associated with major gene clusters encoding systems for 396 
ethanolamine catabolism, heavy metal transport and spermidine uptake. The C-III eut gene cluster 397 
encoded six additional kinases, transporters and transcription regulators absent from the highly 398 
conserved eut operon found in other clades. Ethanolamine is a valuable source of carbon and/or 399 
nitrogen for many bacteria, and eut gene mutations (in C1/C2) impact toxin production in vivo50. 400 
The C-III metal transport gene cluster encoded a chelator of heavy metal ions and a multi-401 
component transport system with specificity for iron, nickel, and glutathione. The conserved 402 
spermidine operon found in all C. difficile clades is thought to play an important role in various 403 
stress responses including during iron limitation51. The additional, divergent spermidine 404 
transporters found in C-III were similar to regions in closely related genera Romboutsia and 405 
Paeniclostridium (data not shown). Together, these data provide preliminary insights into the 406 
biology and ecology of the genomospecies. Most differential loci identified were responsible for 407 
extra or alternate metabolic processes, some not previously reported in C. difficile. It is therefore 408 
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tempting to speculate that the evolution of alternate biosynthesis pathways in these species reflects 409 
distinct ancestries and metabolic responses to evolving within markedly different ecological niches. 410 
This work demonstrates the presence of toxin genes on PaLoc and CdtLoc structures in all 411 
three genomospecies, confirming their clinical relevance. Monotoxin PaLocs were characterised by 412 
the presence of tcdR, tcdB and tcdE, the absence of tcdA and tcdC, and flanking by transposases and 413 
recombinases which mediate LGT20, 21, 52. These findings support the notion that the classical bi-414 
toxin PaLoc common to clades C1-5 was derived by multiple independent acquisitions and stable 415 
fusion of monotoxin PaLocs from ancestral Clostridia52. Moreover, the presence of syntenic PaLoc 416 
and CdtLoc (in ST369, C-I), the latter featuring two copies of cdtA and cdtR, and a recombinase 417 
(xerC), further support this PaLoc fusion hypothesis52.  418 
Bacteriophage holin and endolysin enzymes coordinate host cell lysis, phage release and 419 
toxin secretion53. Monotoxin PaLocs comprising phage-derived holin (tcdE) and endolysin (cwlH) 420 
genes were first described in C-I strains52. We have expanded this previous knowledge by 421 
demonstrating that syntenic tcdE and cwlH are present within monotoxin PaLocs across all three 422 
genomospecies. Moreover, since some strains contained cwlH but lacked toxin genes, this gene 423 
seems to be implicated in toxin acquisition. These data, along with the detection of a complete and 424 
functional29 CdtLoc contained within ΦSemix9P1 in ST343 (C-III), further substantiate the role of 425 
phages in the evolution of toxin loci in C. difficile and related Clostridia 53. 426 
The CdtR and TcdR sequences of the new genomospecies are unique and further work is 427 
needed to determine if these regulators display different mechanisms or efficiencies of toxin 428 
expression12. The presence of dual copies of CdtR in ST369 (C-I) is intriguing, as analogous 429 
duplications in PaLoc regulators have not been documented. One of these CdtR had a mutation at a 430 
key phosphorylation site (Asp61→Asn61) and possibly shows either reduced wild-type activity or 431 
non-functionality, as seen in ST1154. This might explain the presence of a second CdtR copy. 432 
TcdB alone can induce host innate immune and inflammatory responses leading to intestinal 433 
and systemic organ damage55. Our phylogenetic analysis shows TcdB sequences from the three 434 
genomospecies are related to TcdB in Clade 2 members, specifically ST1 and ST41, both virulent 435 
lineages associated with international CDI outbreaks13, 31, and causing classical or variant 436 
(C. sordellii-like) cytopathic effects, respectively56. It would be relevant to explore whether the 437 
divergent PaLoc and CdtLoc regions confer differences in biological activity, as these may present 438 
challenges for the development of effective broad-spectrum diagnostic assays, and vaccines. We 439 
have previously demonstrated that common laboratory diagnostic assays may be challenged by 440 
changes in the PaLoc of C-I strains21. The same might be true for monoclonal antibody-based 441 
treatments for CDI such as bezlotoxumab, known to have distinct neutralizing activities against 442 
different TcdB subtypes57.  443 
Our findings highlight major incongruence in C. difficile taxonomy, identify differential 444 
patterns of diversity among major clades and advance understanding of the evolution of the PaLoc 445 
and CdtLoc. While our analysis is limited solely to the genomic differences between C. difficile 446 
clades, our data provide a robust genetic foundation for future studies to focus on the phenotypic, 447 
ecological and epidemiological features of these interesting groups of strains, including defining the 448 
biological consequences of clade-specific genes and pathogenic differences in vitro and in vivo. Our 449 
findings reinforce that the epidemiology of this important One Health pathogen is not fully 450 
understood. Enhanced surveillance of CDI and WGS of new and emerging strains to better inform 451 
the design of diagnostic tests and vaccines are key steps in combating the ongoing threat posed by 452 
C. difficile. Last, besides C. difficile, we also demonstrate that a similar approach can be applied to 453 
other clostridia making a useful tool for the reclassification of these bacteria. 454 
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Genome collection. We retrieved the entire collection of C. difficile genomes (taxid ID 1496) held 456 
at the NCBI Sequence Read Archive [https://www.ncbi.nlm.nih.gov/sra/]. The raw dataset (as of 1st 457 
January 2020) comprised 12,621 genomes. After filtering for redundancy and Illumina paired-end 458 
data (all platforms and read lengths), 12,304 genomes (97.5%) were available for analysis. 459 
Multi-locus sequence typing. Sequence reads were interrogated for multi-locus sequence type (ST) 460 
using SRST2 v0.1.858. New alleles, STs and clade assignments were verified by submission of 461 
assembled contigs to PubMLST [https://pubmlst.org/cdifficile/]. A species-wide phylogeny was 462 
generated from 659 ST alleles sourced from PubMLST (dated 01-Jan-2020). Alleles were 463 
concatenated in frame and aligned with MAFFT v7.304. A final neighbour-joining tree was 464 
generated in MEGA v1059 and annotated using iToL v4 [https://itol.embl.de/]. 465 
Genome assembly and quality control. Genomes were assembled, annotated and evaluated using 466 
a pipeline comprising TrimGalore v0.6.5, SPAdes v3.6.043, Prokka v1.14.5, and QUAST v2.34416. 467 
Next, Kraken2 v2.0.8-beta60 was used to screen for contamination and assign taxonomic labels to 468 
reads and draft assemblies. Based on metadata, read depth and assembly quality, a final dataset of 469 
260 representative genomes of each ST present in the ENA were used for all subsequent 470 
bioinformatics analyses (C1, n=149; C2, n=35; C3, n=7; C4, n=34; C5, n=18; C-I, n=12; C-II, n=3, 471 
C-III, n=2). The list of representative genomes is available in Table S2 in Supplementary File 1b. 472 
Taxonomic analyses. Species-wide genetic similarity was determined by computation of whole-473 
genome ANI for 260 STs. Both alignment-free and conventional alignment-based ANI approaches 474 
were taken, implemented in FastANI5 v1.3 and the Python module pyani61 v0.2.9, respectively. 475 
FastANI calculates ANI using a unique k-mer based alignment-free sequence mapping engine, 476 
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whilst pyani utilises two different classical alignment ANI algorithms based on BLAST+ (ANIb) 477 
and MUMmer (ANIm). A 96% ANI cut-off was used to define species boundaries4. For taxonomic 478 
placement, ANI was determined for divergent C. difficile genomes against two datasets comprising 479 
(i) members of the Peptostreptococcaceae (n=25)23, and (ii) the complete NCBI RefSeq database 480 
(n=5895 genomes, https://www.ncbi.nlm.nih.gov/refseq/, accessed 14th Jan 2020). Finally, 481 
comparative identity analysis of consensus 16S rRNA sequences for C. mangenotii type strain 482 
DSM1289T23 (accession FR733662.1) and representatives of each C. difficile clade was performed 483 
using Clustal Omega https://www.ebi.ac.uk/Tools/msa/clustalo/. 484 
Estimates of clade and species divergence. BactDating v1.0.162 was applied to the recombination-485 
corrected phylogeny produced by Gubbins (471,708 core-genome sites) with Markov chain Monte 486 
Carlo (MCMC) chains of 107 iterations sampled every 104 iterations with a 50% burn-in. A strict 487 
clock model was used with a rate of 2.5×10-9 to 1.5×10-8 substitutions per site per year, as 488 
previously defined by He et al.13 and Kumar et al.27. The effective sample sizes (ESS) were >200 489 
for all estimated parameters, and traces were inspected manually to ensure convergence. To provide 490 
an independent estimate from BactDating, BEAST v1.10.463 was run on a recombination-filtered 491 
gap-free alignment of 10,466 sites with MCMC chains of 5×108 iterations, with a 9×10-7 burn-in, 492 
that were sampled every 104 iterations. The strict clock model described above was used in 493 
combination with the discrete GTR gamma model of heterogeneity among sites and skyline 494 
population model. MCMC convergence was verified with Tracer v1.7.1 and ESS for all estimated 495 
parameters were >150. For ease of comparison, clade dating from both approaches were transposed 496 
onto a single MLST phylogeny. Tree files are available as Supplementary Files 2-4 at 497 
http://doi.org/10.6084/m9.figshare.12471461.  498 
Pangenome analysis. The 260 ST dataset was used for pangenome analysis with Panaroo v1.1.064 499 
and Roary v3.6.065. Panaroo was run with default thresholds for core assignment (98%) and blastP 500 
identity (95%). Roary was run with a default threshold for core assignment (99%) and two different 501 
thresholds for BlastP identity (95%, 90%). Sequence alignment of the final set of core genes 502 
(Panaroo; n=2,232 genes, 2,606,142 bp) was performed using MAFFT v7.304 and recombinative 503 
sites were filtered using Gubbins v7.30466. A recombinant adjusted alignment of 471,708 504 
polymorphic sites was used to create a core genome phylogeny with RAxML v8.2.12 (GTR gamma 505 
model of among-site rate-heterogeneity), which was visualized alongside pangenome data in 506 
Phandango67. Pangenome dynamics were investigated with PanGP v1.0.116.  507 
Scoary68 v1.6.16 was used to identify genetic loci that were statistically associated with each 508 
clade via a Pangenome-Wide Association Study (pan-GWAS). The Panaroo-derived pangenome 509 
(n=17,470) was used as input for Scoary with the evolutionary clade of each genome depicted as a 510 
discrete binary trait. Scoary was run with 1,000 permutation replicates and genes were reported as 511 
significantly associated with a trait if they attained p-values (empirical, naïve, and Benjamini-512 
Hochberg-corrected) of ≤0.05, a sensitivity and specificity of > 99% and 97.5%, respectively, and 513 
were not annotated as “hypothetical proteins”. All significantly associated genes were reannotated 514 
using prokka and BlastP and functional classification (KEGG orthology) was performed using the 515 
Koala suite of web-based annotation tools69.  516 
Comparative analysis of toxin gene architecture. The 260 ST genome dataset was screened for 517 
the presence of tcdA, tcdB, cdtA and cdtB using the Virulence Factors Database (VFDB) compiled 518 
within ABRicate v1.0 [https://github.com/tseemann/abricate]. Results were corroborated by 519 
screening raw reads against the VFDB using SRST2 v0.1.858. Both approaches employed minimum 520 
coverage and identity thresholds of 90 and 75%, respectively. Comparative analysis of PaLoc and 521 
CdtLoc architecture was performed by mapping of reads with Bowtie2 v.2.4.1 to cognate regions in 522 
reference strain R20291 (ST1, FN545816). All PaLoc and CdtLoc loci investigated showed 523 
sufficient coverage for accurate annotation and structural inference. Genome comparisons were 524 
visualized using ACT and figures prepared with Easyfig21. MUSCLE-aligned TcdB sequences were 525 
visualized in Geneious v2020.1.2 and used to create trees in iToL v4.  526 
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Statistical analyses. All statistical analyses were performed using SPSS v26.0 (IBM, NY, USA). 527 
For pangenome analyses, a Chi-squared test with Yate's correction was used to compare the 528 
proportion of core genes and a One-tailed Mann-Whitney U test was used to demonstrate the 529 
reduction of gene content per genome, with a p-value ≤ 0.05 considered statistically significant.  530 
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